CAROLYN PALMER: Open Payments
NPI 1013565829 · LOUISVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,422 in 51 payments from 8 companies in 2025. Trend: 2023 $1,316 · 2024 $3,012 · 2025 $1,422
Food & beverage: $1,422
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 12 | $360 |
| Genmab U.S., Inc. | 8 | $337 |
| ABBVIE INC. | 6 | $242 |
| Merck Sharp & Dohme LLC | 12 | $224 |
| Eisai Inc. | 9 | $155 |
| Myriad Genetic Laboratories, Inc. | 2 | $59 |
| Verastem, Inc. | 1 | $28 |
| pharmaand GmbH | 1 | $17 |
Products named: LYNPARZA, Tivdak, ELAHERE, Lenvima, KEYTRUDA, MYRISK, AVMAPKI FAKZYNJA CO-PACK, Rubraca.
Industry payments across KY — which companies pay providers there.
